News

As the JavaScript implementation of the popular LangChain framework ... The framework supports various network architectures, including feed-forward networks, recursive neural networks, and long short ...
In an effort to save costs and make its financial resources last longer, Recursion Pharmaceuticals (NASDAQ: RXRX) is slimming ...
Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...
Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.
What better name for a website that recreates the 90s VGA demoscene in javascript than 90s VGA Demoscene? Created by and ...
Fireship on MSN6h
D3.js in 100 Seconds
Data-Driven Documents or D3 is a JavaScript library for drawing SVGs with data. President Donald Trump announced that he and British Prime Minister Kier Starmer have officially signed a trade ...
In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry ...